# Rein Therapeutics, Inc.: Form 8-K, filed Apr 17, 2025

- Company: [Rein Therapeutics, Inc.](/companies/rntx.md) (CIK 1420565)
- Form: 8-K
- Filed: 2025-04-17
- Accepted by EDGAR: Apr 17, 2025, 16:14 ET
- Period: 2025-04-16
- Accession: 0001193125-25-084340
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1420565/000119312525084340/d940643d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1420565/000119312525084340/

## Items reported

- Item 4.01: Change of auditor
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1420565/000119312525084340/d940643d8k.htm

Filed Apr 17, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-084340. Last ingested by Listed: Oct 24, 2026, 15:09 ET. No prices; not investment advice.